about
Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancerMethylated DNA and high total DNA levels in the serum of patients with breast cancer following neoadjuvant chemotherapy are predictive of a poor prognosis.Effect of estrogen receptor α binding on functional DNA methylation in breast cancer.Discovery and validation of DNA hypomethylation biomarkers for liver cancer using HRM-specific probesA methyl-deviator epigenotype of estrogen receptor-positive breast carcinoma is associated with malignant biology.Breast cancer methylomes establish an epigenomic foundation for metastasis.Concordance of DNA methylation pattern in plasma and tumor DNA of Egyptian hepatocellular carcinoma patientsHOXD13 methylation status is a prognostic indicator in breast cancer.Omics-based molecular target and biomarker identification.Exposure to estrogen and ionizing radiation causes epigenetic dysregulation, activation of mitogen-activated protein kinase pathways, and genome instability in the mammary gland of ACI rats.Gut indigenous microbiota and epigenetics.Restoration of the methylation status of hypermethylated gene promoters by microRNA-29b in human breast cancer: A novel epigenetic therapeutic approach.Pyrosequencing quantified methylation level of BRCA1 promoter as prognostic factor for survival in breast cancer patientBiomarkers of the metabolic syndrome and breast cancer prognosis.Protocadherin 17 functions as a tumor suppressor suppressing Wnt/β-catenin signaling and cell metastasis and is frequently methylated in breast cancer.Emerging biomarkers in breast cancer care.Epigenetic modifications as therapeutic targets.Role of epigenetic reprogramming of host genes in bacterial pathogenesis.Laboratory validation of formal concept analysis of the methylation status of microarray-detected genes in primary breast cancer.Evaluation of wild yam (Dioscorea villosa) root extract as a potential epigenetic agent in breast cancer cells.The Predictive Value of PITX2 DNA Methylation for High-Risk Breast Cancer Therapy: Current Guidelines, Medical Needs, and Challenges.Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients.Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay.Methylated DNA and total DNA in serum detected by one-step methylation-specific PCR is predictive of poor prognosis for breast cancer patients.
P2860
Q28743801-ABF03DE4-05D9-495E-B924-50FFC5A135F9Q33778433-E7D4C7F3-2F79-4709-B8F4-206197A3F520Q34000392-B4323D0B-F319-4427-8AB4-3AFE52E6A6C4Q34945934-48548D36-61BD-44CA-A144-17765C39F540Q35069999-5B6C7A09-ABF0-4C03-B2A4-2D497DF128BDQ35136051-B48C58BA-BD31-48CE-8E7B-7015BFB97B69Q35881832-F763BFE4-58D6-4C1F-B6BC-C8596561386FQ36261511-24D5CBA3-731C-4485-9B28-C48DB75E9FA9Q37092087-40AF8E04-5822-4FF5-8B9A-ACC548E391DAQ37092668-5C9B7283-D7E3-45A6-A40A-B696299C477AQ37097933-8615E7B3-363B-4FE8-B0BE-311705A3EA87Q37102684-3F7E541A-B79D-40C1-A08C-EE9AF3C3A982Q37317308-D8D7625A-759B-4AD7-A58D-20B71BF1468AQ37328339-10F6B275-0A79-41A9-AE6D-4A3F9C6F26B3Q37588356-89F3E622-284B-4EC6-9C08-D885437524F2Q37779305-2040E0CF-8FAC-4520-A942-BBAC048F1E70Q37800011-7FB6ACC2-1A11-43E6-8DAE-83E7C8CE67EFQ38162841-5B087C81-DA51-415D-9DEF-FD2E378D0378Q38670584-8CCD9CE1-D54F-47D4-84AF-49E1223DB273Q38963653-B2B6A1DE-7CD0-4B73-88C6-880F8685B4E1Q43375967-315C3CF8-E892-4F0F-AB16-18C3DA6F3316Q49544302-B331A177-1388-446F-B45C-77307C5A2592Q50068205-B1A79DE0-17FA-4FAB-AA23-7BDF5BC3AD22Q54372303-75771DF6-02E7-4483-8FE9-5253700C9138Q54484988-A7BCDDF4-5121-456C-A820-B0BF94503AAE
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
DNA methylation as a biomarker in breast cancer.
@en
DNA methylation as a biomarker in breast cancer.
@nl
type
label
DNA methylation as a biomarker in breast cancer.
@en
DNA methylation as a biomarker in breast cancer.
@nl
prefLabel
DNA methylation as a biomarker in breast cancer.
@en
DNA methylation as a biomarker in breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
DNA methylation as a biomarker in breast cancer.
@en
P2093
Astrid L Margossian
John Foekens
John Wm Martens
Manfred Schmitt
P2860
P304
P356
10.2217/FON.09.89
P407
P577
2009-10-01T00:00:00Z